Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on July 31, 2003; DOI 10.1182/blood-2003-03-0669.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-03-0669v1
102/12/4090    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brandt, K.
Right arrow Articles by Ruckert, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brandt, K.
Right arrow Articles by Ruckert, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted March 3, 2003
Accepted July 21, 2003

Interleukin-21 inhibits dendritic cell activation and maturation

Katja Brandt, Silvia Bulfone-Paus, Donald C Foster, and Rene Ruckert*

Department of Immunology and Cell Biology, Research Center Borstel, Borstel, Germany
ZymoGenetics Inc, Seattle, WA, USA

* Corresponding author; email: rrueckert{at}fz-borstel.de.

IL-21 is a newly described cytokine with homology to IL-4 and IL-15. They belong to a cytokine family, which use the common {gamma}-chain for signaling but also have their private high-affinity receptors. Since IL-4 is well-known to modulate differentiation and activation of dendritic cells (DC), we analyzed effects of IL-21 in comparison to IL-15 on DC differentiation, maturation and function. Here we show that DCs generated with GMCSF in the presence of IL-21 (IL-21DCs) differentiated into phenotypic and functional altered DCs characterized by reduced MHCII expression, high antigen-uptake and low stimulatory capacity for T-cell activation in vitro. Additionally, IL-21DCs completely failed to induce Ag-specific, T-cell mediated contact-hypersensitivity. Furthermore, IL-21 blocked LPS induced activation and maturation of DCs, which was not mediated by release of the anti-inflammatory cytokine IL-10. In contrast, if IL-15 was supplemented to GMCSF, DCs differentiated into mature APCs with low antigen-uptake and high significantly increased capacities to stimulate T-cells in vitro and in vivo. Taken together these results identify a dichotomous action of these structural related cytokines on DCs, establishing IL-21 as inhibitory cytokine on DC activation and IL-15 as potent stimulator of DC function, making both cytokines interesting targets for therapeutical manipulation of DC-induced immune-reactions.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
H. Sondergaard, J. M. Coquet, A. P. Uldrich, N. McLaughlin, D. I. Godfrey, P. V. Sivakumar, K. Skak, and M. J. Smyth
Endogenous IL-21 Restricts CD8+ T Cell Expansion and Is not Required for Tumor Immunity
J. Immunol., December 1, 2009; 183(11): 7326 - 7336.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S.-H. Lee, K.-S. Kim, N. Fodil-Cornu, S. M. Vidal, and C. A. Biron
Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection
J. Exp. Med., September 28, 2009; 206(10): 2235 - 2251.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G.-Y. Seo, J. Youn, and P.-H. Kim
IL-21 ensures TGF-{beta}1-induced IgA isotype expression in mouse Peyer's patches
J. Leukoc. Biol., May 1, 2009; 85(5): 744 - 750.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. P.R. Sutherland, T. Van Belle, A. L. Wurster, A. Suto, M. Michaud, D. Zhang, M. J. Grusby, and M. von Herrath
Interleukin-21 Is Required for the Development of Type 1 Diabetes in NOD Mice
Diabetes, May 1, 2009; 58(5): 1144 - 1155.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Spolski, H.-P. Kim, W. Zhu, D. E. Levy, and W. J. Leonard
IL-21 Mediates Suppressive Effects via Its Induction of IL-10
J. Immunol., March 1, 2009; 182(5): 2859 - 2867.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Ansen, M. O. Butler, A. Berezovskaya, A. P. Murray, K. Stevenson, L. M. Nadler, and N. Hirano
Dissociation of Its Opposing Immunologic Effects Is Critical for the Optimization of Antitumor CD8+ T-Cell Responses Induced by Interleukin 21
Clin. Cancer Res., October 1, 2008; 14(19): 6125 - 6136.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
W. J. Leonard, R. Zeng, and R. Spolski
Interleukin 21: a cytokine/cytokine receptor system that has come of age
J. Leukoc. Biol., August 1, 2008; 84(2): 348 - 356.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. S. Hinrichs, R. Spolski, C. M. Paulos, L. Gattinoni, K. W. Kerstann, D. C. Palmer, C. A. Klebanoff, S. A. Rosenberg, W. J. Leonard, and N. P. Restifo
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
Blood, June 1, 2008; 111(11): 5326 - 5333.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
A H Sawalha, K M Kaufman, J A Kelly, A J Adler, T Aberle, J Kilpatrick, E K Wakeland, Q-Z Li, A E Wandstrat, D R Karp, et al.
Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus
Ann Rheum Dis, April 1, 2008; 67(4): 458 - 461.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Hansen, A. M. Westendorf, S. Reinwald, D. Bruder, S. Deppenmeier, L. Groebe, M. Probst-Kepper, A. D. Gruber, R. Geffers, and J. Buer
Chronic Antigen Stimulation In Vivo Induces a Distinct Population of Antigen-Specific Foxp3 CD25 Regulatory T Cells
J. Immunol., December 15, 2007; 179(12): 8059 - 8068.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
I. D. Davis, K. Skak, M. J. Smyth, P. E.G. Kristjansen, D. M. Miller, and P. V. Sivakumar
Interleukin-21 Signaling: Functions in Cancer and Autoimmunity
Clin. Cancer Res., December 1, 2007; 13(23): 6926 - 6932.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Hiromura, T. Kishida, H. Nakano, T. Hama, J. Imanishi, Y. Hisa, and O. Mazda
IL-21 Administration into the Nostril Alleviates Murine Allergic Rhinitis
J. Immunol., November 15, 2007; 179(10): 7157 - 7165.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. R. Barker, J. G. Parvani, D. Meyer, A. S. Hey, K. Skak, and N. L. Letvin
IL-21 Induces Apoptosis of Antigen-Specific CD8+ T Lymphocytes
J. Immunol., September 15, 2007; 179(6): 3596 - 3603.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
V. Ostiguy, E.-L. Allard, M. Marquis, J. Leignadier, and N. Labrecque
IL-21 promotes T lymphocyte survival by activating the phosphatidylinositol-3 kinase signaling cascade
J. Leukoc. Biol., September 1, 2007; 82(3): 645 - 656.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Casey and M. F. Mescher
IL-21 Promotes Differentiation of Naive CD8 T Cells to a Unique Effector Phenotype
J. Immunol., June 15, 2007; 178(12): 7640 - 7648.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Zeng, R. Spolski, E. Casas, W. Zhu, D. E. Levy, and W. J. Leonard
The molecular basis of IL-21-mediated proliferation
Blood, May 15, 2007; 109(10): 4135 - 4142.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Bulanova, V. Budagian, E. Duitman, Z. Orinska, H. Krause, R. Ruckert, N. Reiling, and S. Bulfone-Paus
Soluble Interleukin (IL)-15R{alpha} Is Generated by Alternative Splicing or Proteolytic Cleavage and Forms Functional Complexes with IL-15
J. Biol. Chem., May 4, 2007; 282(18): 13167 - 13179.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Coquet, K. Kyparissoudis, D. G. Pellicci, G. Besra, S. P. Berzins, M. J. Smyth, and D. I. Godfrey
IL-21 Is Produced by NKT Cells and Modulates NKT Cell Activation and Cytokine Production
J. Immunol., March 1, 2007; 178(5): 2827 - 2834.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Rutella, S. Danese, and G. Leone
Tolerogenic dendritic cells: cytokine modulation comes of age
Blood, September 1, 2006; 108(5): 1435 - 1440.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Pelletier and D. Girard
Differential Effects of IL-15 and IL-21 in Myeloid (CD11b+) and Lymphoid (CD11b-) Bone Marrow Cells
J. Immunol., July 1, 2006; 177(1): 100 - 108.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Strengell, A. Lehtonen, S. Matikainen, and I. Julkunen
IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells
J. Leukoc. Biol., June 1, 2006; 79(6): 1279 - 1285.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. A. Perez, L. G. Mahaira, P. A. Sotiropoulou, A. D. Gritzapis, E. G. Iliopoulou, D. K. Niarchos, N. T. Cacoullos, Y. G. Kavalakis, A. I. Antsaklis, N. N. Sotiriadou, et al.
Effect of IL-21 on NK cells derived from different umbilical cord blood populations
Int. Immunol., January 1, 2006; 18(1): 49 - 58.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
V. Budagian, E. Bulanova, Z. Orinska, E. Duitman, K. Brandt, A. Ludwig, D. Hartmann, G. Lemke, P. Saftig, and S. Bulfone-Paus
Soluble Axl Is Generated by ADAM10-Dependent Cleavage and Associates with Gas6 in Mouse Serum
Mol. Cell. Biol., November 1, 2005; 25(21): 9324 - 9339.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Li, M. Bleakley, and C. Yee
IL-21 Influences the Frequency, Phenotype, and Affinity of the Antigen-Specific CD8 T Cell Response
J. Immunol., August 15, 2005; 175(4): 2261 - 2269.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. L. Alves, F. A. Arosa, and R. A. W. van Lier
IL-21 Sustains CD28 Expression on IL-15-Activated Human Naive CD8+ T Cells
J. Immunol., July 15, 2005; 175(2): 755 - 762.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Ruckert, K. Brandt, A. Braun, H.-G. Hoymann, U. Herz, V. Budagian, H. Durkop, H. Renz, and S. Bulfone-Paus
Blocking IL-15 Prevents the Induction of Allergen-Specific T Cells and Allergic Inflammation In Vivo
J. Immunol., May 1, 2005; 174(9): 5507 - 5515.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. L. Vollmer, R. Liu, M. Price, S. Rhodes, A. La Cava, and F.-D. Shi
Differential Effects of IL-21 during Initiation and Progression of Autoimmunity against Neuroantigen
J. Immunol., March 1, 2005; 174(5): 2696 - 2701.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Pelletier, A. Bouchard, and D. Girard
In Vivo and In Vitro Roles of IL-21 in Inflammation
J. Immunol., December 15, 2004; 173(12): 7521 - 7530.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Strengell, I. Julkunen, and S. Matikainen
IFN-{alpha} regulates IL-21 and IL-21R expression in human NK and T cells
J. Leukoc. Biol., August 1, 2004; 76(2): 416 - 422.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Jin, R. Carrio, A. Yu, and T. R. Malek
Distinct Activation Signals Determine whether IL-21 Induces B Cell Costimulation, Growth Arrest, or Bim-Dependent Apoptosis
J. Immunol., July 1, 2004; 173(1): 657 - 665.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020